Analysis for SoftBank Group
Analysis summary
SoftBank Group (9984.JP) currently has a total score of 58 points, placing it in the neutral range. The score is made up of Performance (84), Stability (22) and Trend (49). The profile is clearly uneven: Performance stands out while Stability lags.
Performance scores 84 points (very strong). Key strength: 1Y return at 86.8 %. Even the weakest return is still strong in absolute terms: 5Y return at 109.6 %. This points to a sharper upswing more recently.
Stability scores 22 points (weak). Key strength: return/volatility ratio at 1.34. Main drag: volatility (365d, annualized) at 65.0 %. That implies very high day-to-day swings. Higher Stability points are better and typically reflect calmer swings and smaller drawdowns—but prices can still fall.
Trend scores 49 points (neutral). Key strength: 12M momentum at 68.4 %. Weaker metric: trend strength at -0.73.
Overall, the picture is mixed: Performance does the heavy lifting while Stability holds the score back. On a metric level, 1Y return stands out, while volatility (365d, annualized) is the main weak spot.
(Historical evaluation, not investment advice.)
Metrics
Performance
Stability
FAQ
- What investor type does SoftBank Group fit best in FoxScore?
- SoftBank Group fits a more opportunity-seeking investor type in FoxScore: performance is the strongest sub-score. That suggests above-average historical returns — but check stability to ensure the performance wasn’t “paid for” with high volatility or deep drawdowns.
- How meaningful is the available history for SoftBank Group?
- SoftBank Group currently has about 15 years of price history available. That covers multiple market cycles including crisis phases, making long-term interpretation of returns, drawdowns and trend shifts more reliable.
- What is FoxScore good for — and what is it not for?
- FoxScore is an analysis and comparison tool: it helps you sort assets quickly, compare profiles and spot strengths/weaknesses. It’s not a substitute for your own research or fundamental analysis, and it’s not a buy/sell recommendation.